ZnuD, a potential candidate for a simple and universal neisseria meningitidis vaccine

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 1915-1927

  Hubert, Kerstin ^a   Devos, Nathalie ^b   Mordhorst, Ines ^a   Tans, Christine ^b   Baudoux, Guy ^b   Feron, Christiane ^b   Goraj, Karine ^b   Tommassen, Jan ^c   Vogel, Ulrich ^a   Poolman, Jan T ^b   Weynants, Vincent ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b GSK   (Belgium)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; BACTERIAL VACCINE; CROSS REACTING ANTIGEN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ZNUD;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GROWTH; GROWTH CURVE; GUINEA PIG; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM BACTERICIDAL ACTIVITY;

EID: 84877791728     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01312-12     Document Type: Article

References (40)

1. Finne J, Leinonen M, Mäkelä PH. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 322:355-357.
2. Nedelec J, Boucraut J, Garnier JM, Bernard D, Rougon G. 1990. Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis. J. Neuroimmunol. 29:49-56.
3. Frasch CE, van Alphen L, Holst J, Poolman JT, Rosenqvist E. 2001. Outer membrane protein vesicle vaccines for meningococcal disease, p 81-107. In Pollard AJ, Maiden MCJ (ed), Meningococcal vaccines: methods and protocols. Humana Press, Totowa, NJ.
4. Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, Rosenqvist E. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27: B3-B12. doi:10.1016/j.vaccine.2009.04.071.
5. Czumbel I. 2011. The epidemiology of invasive meningococcal disease in Europe, 2008 and 2009, p 3. Abstr. 11th Congr. Eur. Meningococcal Dis. Soc., Ljubljana, Slovenia, 18 to 20 May 2011.
6. Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, Knauf M, Ooi P, Smith RP, Weise P, Wetherell M, Xie X, Zagursky R, Zhang Y, Zlotnick GW. 2004. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect. Immun. 72:2088-2100.
7. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Aricò B, Brunelli B, Pieri A, Santini L, Savino S, Serruto D, Litt D, Kroll S, Welsch JA, Granoff DM, Rappuoli R, Pizza M. 2003. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197:789-799.
8. Stork M, Bos MP, Jongerius I, de Kok N, Schilders I, Weynants VE, Poolman JT, Tommassen J. 2010. An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential. PLoS Pathog. 6:e1000969. doi:10.1371/journal.ppat.1000969.
9. Patzer SI, Hantke K. 2000. The zinc-responsive regulator Zur and its control of the znu gene cluster encoding the ZnuABC zinc uptake system in Escherichia coli. J. Biol. Chem. 275:24321-24332.
10. Kumar P, Sannigrahi S, Tzeng Y-L. 2012. The Neisseria meningitidis ZnuD zinc receptor contributes to interactions with epithelial cells and supports heme utilization when expressed in Escherichia coli. Infect. Immun. 80:657-667.
11. Claus H, Maiden MCJ, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, Hessler F, Frosch M, Vogel U. 2005. Genetic analysis of meningococci carried by children and young adults. J. Infect. Dis. 191:1263-1271.
12. Lappann M, Haagensen JAJ, Claus H, Vogel U, Molin S. 2006. Meningococcal biofilm formation: structure, development and phenotypes in a standardized continuous flow system. Mol. Microbiol. 62: 1292-1309.
13. Weynants V, Denoël P, Devos N, Janssens D, Feron C, Goraj K, Momin P, Monnom D, Tans C, Vandercammen A, Wauters F, Poolman JT. 2009. Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect. Immun. 77:2084-2093.
14. Griffiths NJ, Hill DJ, Borodina E, Sessions RB, Devos NI, Feron CM, Poolman JT, Virji M. 2011. Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol. Microbiol. 82:1129-1149.
15. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
16. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
17. Weynants VE, Feron CM, Goraj KK, Bos MP, Denoël PA, Verlant VG, Tommassen J, Peak IRA, Judd RC, Jennings MP, Poolman JT. 2007. Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis. Infect. Immun. 75:5434-5442.
18. Devos N, Tans C, Momin P, Plisnier M, Weynants V, Feron C, Poolman JT. 2012. Neisseria meningitidis serogroup B lipooligosaccharide genotyping reveals high prevalence of L2 strains in Spain and unexpected relationship with factor H-binding protein expression. Microbes Infect. 14:979-988.
19. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
20. Rose PW, Beran B, Bi C, Bluhm WF, Dimitropoulos D, Goodsell DS, Prliæ A, Quesada M, Quinn GB, Westbrook JD, Young J, Yukich B, Zardecki C, Berman HM, Bourne PE. 2011. The RCSB Protein Data Bank: redesigned Web site and Web services. Nucleic Acids Res. 39:D392- D401. doi:10.1093/nar/gkq1021.
21. Noinaj N, Guillier M, Barnard TJ, Buchanan SK. 2010. TonB-dependent transporters: regulation, structure, and function. Annu. Rev. Microbiol. 64:43-60.
22. Buchanan SK, Smith BS, Venkatramani L, Xia D, Esser L, Palnitkar M, Chakraborty R, van der Helm D, Deisenhofer J. 1999. Crystal structure of the outer membrane active transporter FepA from Escherichia coli. Nat. Struct. Biol. 6:56-63.
23. Cobessi D, Meksem A, Brillet K. 2010. Structure of the heme/ hemoglobin outer membrane receptor ShuA from Shigella dysenteriae: heme binding by an induced fit mechanism. Proteins 78:286-294.
24. Buchanan SK, Lukacik P, Grizot S, Ghirlando R, Ali MMU, Barnard TJ, Jakes KS, Kienker PK, Esser L. 2007. Structure of colicin I receptor bound to the R-domain of colicin Ia: implications for protein import. EMBO J. 26:2594-2604.
25. Buchan DWA, Ward SM, Lobley AE, Nugent TCO, Bryson K, Jones DT. 2010. Protein annotation and modelling servers at University College London. Nucleic Acids Res. 38:W563-W568. doi:10.1093/nar/gkq427.
26. Bagos PG, Liakopoulos TD, Spyropoulos IC, Hamodrakas SJ. 2004. PRED-TMBB: a Web server for predicting the topology of β-barrel outer membrane proteins. Nucleic Acids Res. 32:W400-W404. doi:10.1093/nar /gkh417.
27. Randall A, Cheng J, Sweredoski M, Baldi P. 2008. TMBpro: secondary structure, β-contact and tertiary structure prediction of transmembrane β-barrel proteins. Bioinformatics 24:513-520.
28. Holm L, Rosenström P. 2010. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38:W545-W549. doi:10.1093/nar/gkq366.
29. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen M-Y, Pieper U, Sali A. 2006. Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics Chapter 5:Unit 5.6. doi:10.1002/0471250953.bi0506s15.
30. Benkert P, Künzli M, Schwede T. 2009. QMEAN server for protein model quality estimation. Nucleic Acids Res. 37:W510-W514. doi:10 .1093/nar/gkp322.
31. Koebnik R. 2005. TonB-dependent trans-envelope signalling: the exception or the rule? Trends Microbiol. 13:343-347.
32. Koeberling O, Welsch JA, Granoff DM. 2007. Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870. Vaccine 25:1912-1920.
33. Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, Andrews N, Barchha R, Harrison E, Lowe A, Boxer E, Heaton C, Balmer P, Kaczmarski E, Oster P, Gorringe A, Borrow R, Miller E. 2006. Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac. Infect. Immun. 74:4557-4565.
34. 2+ in bovine milk and plasma. J. Nutr. 125:1904-1910.
35. Vallee BL, Falchuk KH. 1993. The biochemical basis of zinc physiology. Physiol. Rev. 73:79-118.
36. Echenique-Rivera H, Muzzi A, Del Tordello E, Seib KL, Francois P, Rappuoli R, Pizza M, Serruto D. 2011. Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog. 7:e1002027. doi:10.1371/journal.ppat.1002027.
37. Rokbi B, Mignon M, Maitre-Wilmotte G, Lissolo L, Danve B, Caugant DA, Quentin-Millet MJ. 1997. Evaluation of recombinant transferrin- binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect. Immun. 65:55-63.
38. Brehony C, Wilson DJ, Maiden MCJ. 2009. Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology 155:4155-4169.
39. Findlow J, Borrow R, Snape MD, Dawson T, Holland A, John TM, Evans A, Telford KL, Ypma E, Toneatto D, Oster P, Miller E, Pollard AJ. 2010. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51:1127-1137.
40. Lucidarme J, Tan L, Exley RM, Findlow J, Borrow R, Tang CM. 2011. Characterisation of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen, factor H binding protein. Clin. Vaccine Immunol. 18:1002-1014.